1. Home
  2. DERM vs OPRX Comparison

DERM vs OPRX Comparison

Compare DERM & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DERM
    SELLHOLDBUYas of 15 hours ago
  • OPRX
    SELLHOLDBUYas of 15 hours ago
  • Stock Information
  • Founded
  • DERM 2014
  • OPRX 2006
  • Country
  • DERM United States
  • OPRX United States
  • Employees
  • DERM N/A
  • OPRX N/A
  • Industry
  • DERM Biotechnology: Pharmaceutical Preparations
  • OPRX Business Services
  • Sector
  • DERM Health Care
  • OPRX Consumer Discretionary
  • Exchange
  • DERM Nasdaq
  • OPRX Nasdaq
  • Market Cap
  • DERM 87.4M
  • OPRX 111.2M
  • IPO Year
  • DERM 2021
  • OPRX N/A
  • Fundamental
  • Price
  • DERM $4.00
  • OPRX $5.41
  • Analyst Decision
  • DERM Strong Buy
  • OPRX Buy
  • Analyst Count
  • DERM 3
  • OPRX 8
  • Target Price
  • DERM $9.50
  • OPRX $9.06
  • AVG Volume (30 Days)
  • DERM 66.0K
  • OPRX 294.8K
  • Earning Date
  • DERM 11-12-2024
  • OPRX 11-13-2024
  • Dividend Yield
  • DERM N/A
  • OPRX N/A
  • EPS Growth
  • DERM N/A
  • OPRX N/A
  • EPS
  • DERM N/A
  • OPRX N/A
  • Revenue
  • DERM $57,771,000.00
  • OPRX $88,179,506.00
  • Revenue This Year
  • DERM N/A
  • OPRX $27.42
  • Revenue Next Year
  • DERM $36.49
  • OPRX $11.97
  • P/E Ratio
  • DERM N/A
  • OPRX N/A
  • Revenue Growth
  • DERM N/A
  • OPRX 40.40
  • 52 Week Low
  • DERM $2.85
  • OPRX $3.78
  • 52 Week High
  • DERM $6.89
  • OPRX $16.65
  • Technical
  • Relative Strength Index (RSI)
  • DERM 32.81
  • OPRX 52.67
  • Support Level
  • DERM $3.78
  • OPRX $4.80
  • Resistance Level
  • DERM $4.48
  • OPRX $6.04
  • Average True Range (ATR)
  • DERM 0.32
  • OPRX 0.48
  • MACD
  • DERM -0.02
  • OPRX 0.08
  • Stochastic Oscillator
  • DERM 18.18
  • OPRX 66.13

Stock Price Comparison Chart: DERM vs OPRX

DERM
OPRX
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250102030405060708090100DERM VS OPRX

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

About OPRX OptimizeRx Corporation

OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use